#United States #Jacksonville #ActiGraft #RedDress #Legacy Medical

RedDress and Legacy Medical Consultants Unite for Wound Care Innovation

In a significant step towards improving chronic wound management, RedDress, a renowned developer of the FDA-cleared ActiGraft® wound management system, has appointed Legacy Medical Consultants as its exclusive distributor in the United States. This strategic collaboration is poised to expand the availability of ActiGraft® across various care settings, ensuring that more patients have access to cutting-edge treatment options.

Details of the Partnership

The agreement between RedDress and Legacy Medical Consultants (LMC) grants LMC exclusive distribution rights for the ActiGraft® system in pivotal healthcare environments, including hospitals, outpatient wound care centers, the Department of Veterans Affairs (VA), and Department of Defense (DoD) facilities. This partnership, effective immediately, is set to enhance sales, marketing, and customer support functions for ActiGraft® under a multi-year contract.

Both companies will actively collaborate to expand payer coverage and GPO (Group Purchasing Organization) contracting, as well as support ongoing research initiatives. The overarching goal of this collaboration is to boost the potential impact of the ActiGraft® solution in treating chronic wounds.

The Challenge of Chronic Wounds

Chronic wounds, often described as a silent epidemic, affect over 6.5 million individuals in the U.S. alone, which translates to approximately one in every 38 adults. The prevalence of conditions such as diabetes, obesity, and an aging population has escalated the demand for effective wound care therapies. This situation highlights the critical need for innovative solutions in managing persistent wounds.

Understanding ActiGraft®

The ActiGraft® system represents a breakthrough in the treatment of chronic wounds. This advanced autologous graft utilizes the patient’s own blood to generate a whole blood clot that replenishes the dysfunctional extracellular matrix typically encountered in stalled wounds. This mechanism fosters the reactivation of the body’s intrinsic healing process, making ActiGraft® particularly suitable for patients on blood thinners or those with exposed bones and tendons.

Alon Kushnir, CEO and Co-Founder of RedDress, emphasized the importance of this partnership, stating, "Legacy Medical Consultants' high-caliber team and allograft expertise are the perfect complement to our state-of-the-art autologous graft technology. This collaboration marks a pivotal milestone in broadening access to ActiGraft, transforming the treatment landscape for chronic wounds."

Legacy Medical's Vision

Jonathan Knutz, CEO of Legacy Medical Consultants, articulated the mission of Legacy as pioneering solutions in wound care that meet unmet clinical needs. He remarked, "Patients should not have to face the fear of losing a limb due to chronic wounds. Our partnership with RedDress is vital because it provides patients with treatment options that may not have been accessible otherwise. ActiGraft® adds an essential layer to our portfolio of high-quality allografts."

Accessibility of ActiGraft®

Starting today, ActiGraft® is available for order via Legacy Medical’s Customer Service Department, ensuring a seamless transition for existing RedDress clients without any disruption in supply or support. Interested healthcare providers can reach out to Legacy Medical directly via email or phone to place their orders.

About the Companies

Legacy Medical Consultants

Legacy Medical Consultants is dedicated to elevating patient care in the wound management domain. The team of professionals at LMC focuses on complex wound care, bridging the gap between providers and patients to improve outcomes and quality of life for those dealing with chronic wounds. For more information, visit Legacy Medical Consultants.

RedDress

Headquartered in Jacksonville, Florida, RedDress is a privately held biomedical firm driven by the goal of revolutionizing wound care. With multiple patents on their proprietary blood clot technology, they are committed to advancing clinical research and enhancing chronic wound management. To learn more, visit RedDress Medical.

The partnership between RedDress and Legacy Medical Consultants signifies a substantial leap forward in comprehensive wound management, striving to ensure that more patients receive the personalized and effective care they need.